Voyager Therapeutics is a biotechnology company based in Lexington, MA, dedicated to revolutionizing the treatment of neurological diseases through genetic medicines. Their pipeline includes innovative therapies for Alzheimer's disease, ALS, Parkinson's disease, and other central nervous system disorders.
With a focus on advancing transformative neurogenetic medicines, Voyager Therapeutics is driven by a team of dedicated professionals who share a passion for making a difference in the field of neurology. Their cutting-edge TRACER AAV capsid discovery platform enables exceptional delivery of therapies across the blood-brain barrier, offering new hope for patients worldwide.
Generated from the website